Results 41 to 50 of about 6,319 (109)

[Myelopathy secondary to thoracic actinomycetoma]. [PDF]

Rev Med Inst Mex Seguro Soc
Damián-Zapién A, Covarrubias-Gutiérrez D, Rodríguez-Virgen JE, Corona-Torres MC, Serna-Castellanos KE.   +4 more
europepmc   +1 more source

The development of a multiplex recombinase polymerase amplification reaction to detect the most common causative agents of eumycetoma. [PDF]

Eur J Clin Microbiol Infect Dis
Konings M, Siddig E, Eadie K, Minlekib CP, Faye M, Sow D, Fahal A, Verbon A, van de Sande W.   +8 more
europepmc   +1 more source

Black Grain Mycetoma by a Hyaline Fungus: It is Possible?

Indian J Dermatol, 2023
Kumar R, Chatterjee M, Ranjan R.
europepmc   +1 more source

A Rare Case of Oral Cavity Eumycetoma. [PDF]

Ann Maxillofac Surg, 2023
Wadde KR, Khaire SD, Joy T, Sardar MA, Kri M, Venkatakrishnan L.   +5 more
europepmc   +1 more source

An updated list of eumycetoma causative agents and their differences in grain formation and treatment response. [PDF]

Clin Microbiol Rev
van de Sande WWJ, Fahal AH.
europepmc   +1 more source

Fungal Infections of Implantation: More Than Five Years of Cases of Subcutaneous Fungal Infections Seen at the UK Mycology Reference Laboratory. [PDF]

J Fungi (Basel), 2022
Borman AM, Fraser M, Patterson Z, Linton CJ, Palmer M, Johnson EM.   +5 more
europepmc   +1 more source

Phaeohyphomycoses in kidney transplant recipients: A 10-year retrospective study from the French West Indies. [PDF]

Med Mycol
Thomas C, Boullé C, Claude PA, Claudeon J, Cossard Y, Devatine S, Antonowicz J, Nicolas M, Amarsy R, Markowicz S, Coussement J, Schepers K, Haboub M, Musson P, Piednoir P, Lanternier F, Epelboin L, Hermoso DG, Tardieu L.   +18 more
europepmc   +1 more source

In vitro susceptibility testing for black grain eumycetoma causative agents. [PDF]

Trans R Soc Trop Med Hyg, 2021
van de Sande WWJ.
europepmc   +1 more source

Kinome analysis of Madurella mycetomatis identified kinases in the cell wall integrity pathway as novel potential therapeutic drug targets in eumycetoma caused by Madurella mycetomatis. [PDF]

PLoS Negl Trop Dis
Konings M, Strepis N, Manabe RI, Hasegawa A, Chaudhari S, du Pré S, Schippers M, Tagami M, Ma J, Okazaki Y, Todd M, Biersack B, Masand V, Verbon A, Kasukawa T, Abugessaisa I, van de Sande WWJ.   +16 more
europepmc   +1 more source

Screening the pandemic response box identified benzimidazole carbamates, Olorofim and ravuconazole as promising drug candidates for the treatment of eumycetoma. [PDF]

PLoS Negl Trop Dis, 2022
Lim W, Nyuykonge B, Eadie K, Konings M, Smeets J, Fahal A, Bonifaz A, Todd M, Perry B, Samby K, Burrows J, Verbon A, van de Sande W.   +12 more
europepmc   +1 more source